Lipid metabolism reprogramming in chronic obstructive pulmonary disease
Abstract Chronic Obstructive Pulmonary Disease (COPD) is a complex and diverse respiratory disorder, characterized by ongoing respiratory symptoms and restricted airflow. The major clinical manifestations typically encompass chronic cough, sputum production, and wheezing. The main pathological chara...
Saved in:
| Main Authors: | Qianqian Liang, Yide Wang, Zheng Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Molecular Medicine |
| Online Access: | https://doi.org/10.1186/s10020-025-01191-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution of global disease burden, risk factors and trend projection of chronic obstructive pulmonary disease among individuals under 50 years old from 1990 to 2021
by: WANG Yide, et al.
Published: (2025-06-01) -
The Role of Lipid Metabolic Reprogramming in the Hibernation of Chipmunks
by: Mingrui Huang, et al.
Published: (2025-07-01) -
LIPID-LOWERING AND PLEIOTROPIC EFFECTS OF ATORVASTATIN IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: SVETLANA A. Smakotina, et al.
Published: (2017-06-01) -
Metabolic Aging as an Increased Risk for Chronic Obstructive Pulmonary Disease
by: Claire J. Guo, et al.
Published: (2024-11-01) -
Associations between serum lipid profiles and the incidence of chronic obstructive pulmonary disease in the UK Biobank
by: Mengxia Li, et al.
Published: (2025-08-01)